| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 10 | +184K | 90.2% | $5.71 | +$1.05M |
| Sells | 3 | -20K | 9.8% | $6.17 | -$123K |
| Net | +7 | +164K | 80.4% | +$925K |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Jon P. Stonehouse | President & CEO, Director | $6.48M | +$167K | +2.64% | May 13, 2024 |
| Yarlagadda S. Babu | Chief Discovery Officer | $1.81M | Nov 14, 2022 | ||
| Charles K. Gayer | Chief Commercial Officer | $1.68M | +$164K | +10.8% | May 13, 2024 |
| Alane P. Barnes | Chief Legal Officer | $1.66M | +$27.7K | +1.69% | May 13, 2024 |
| Helen M. Thackray | Chief R&D Officer | $1.59M | +$176K | +12.4% | May 14, 2024 |
| Anthony Doyle | Chief Financial Officer | $1.49M | +$202K | +15.8% | May 14, 2024 |
| Robert Alexander Ingram | Director | $606K | Feb 28, 2023 | ||
| Nancy J. Hutson | Director | $572K | +$31.9K | +5.9% | Jun 12, 2024 |
| Vincent Milano | Director | $571K | +$93.8K | +19.7% | Nov 29, 2024 |
| Steve Aselage | Director | $469K | +$16K | +3.53% | Jun 12, 2024 |
| Kenneth B. Lee Jr | Director | $417K | Jun 13, 2023 | ||
| Steven K. Galson | Director | $377K | +$120K | +46.9% | Jun 12, 2024 |
| Theresa Heggie | Director | $323K | -$40.9K | -11.2% | Jun 12, 2024 |
| Alan G. Levin | Director | $316K | +$50K | +18.8% | Jun 12, 2024 |
| George B. Abercrombie | Director | $235K | Jun 12, 2024 | ||
| William P. Sheridan | Chief Medical Officer | $230K | Mar 10, 2022 | ||
| Amy E. McKee | Director | $176K | -$54.4K | -23.6% | Jun 24, 2024 |
| Machelle Sanders | Director | $166K | -$28.1K | -14.5% | Jun 17, 2024 |
| Michael L. Jones | Exec. Director, Finance - PAO | $101K | Dec 19, 2022 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|